全文获取类型
收费全文 | 19872篇 |
免费 | 2240篇 |
国内免费 | 393篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 473篇 |
妇产科学 | 141篇 |
基础医学 | 709篇 |
口腔科学 | 35篇 |
临床医学 | 4522篇 |
内科学 | 8062篇 |
皮肤病学 | 42篇 |
神经病学 | 342篇 |
特种医学 | 3013篇 |
外国民族医学 | 2篇 |
外科学 | 1140篇 |
综合类 | 2110篇 |
现状与发展 | 2篇 |
预防医学 | 270篇 |
眼科学 | 628篇 |
药学 | 591篇 |
12篇 | |
中国医学 | 126篇 |
肿瘤学 | 252篇 |
出版年
2024年 | 27篇 |
2023年 | 322篇 |
2022年 | 430篇 |
2021年 | 651篇 |
2020年 | 908篇 |
2019年 | 932篇 |
2018年 | 870篇 |
2017年 | 734篇 |
2016年 | 653篇 |
2015年 | 753篇 |
2014年 | 1221篇 |
2013年 | 1128篇 |
2012年 | 904篇 |
2011年 | 1030篇 |
2010年 | 769篇 |
2009年 | 878篇 |
2008年 | 932篇 |
2007年 | 998篇 |
2006年 | 924篇 |
2005年 | 748篇 |
2004年 | 688篇 |
2003年 | 667篇 |
2002年 | 558篇 |
2001年 | 554篇 |
2000年 | 444篇 |
1999年 | 408篇 |
1998年 | 426篇 |
1997年 | 408篇 |
1996年 | 313篇 |
1995年 | 332篇 |
1994年 | 257篇 |
1993年 | 254篇 |
1992年 | 232篇 |
1991年 | 177篇 |
1990年 | 111篇 |
1989年 | 88篇 |
1988年 | 101篇 |
1987年 | 105篇 |
1986年 | 70篇 |
1985年 | 101篇 |
1984年 | 95篇 |
1983年 | 68篇 |
1982年 | 74篇 |
1981年 | 39篇 |
1980年 | 31篇 |
1979年 | 21篇 |
1978年 | 23篇 |
1977年 | 17篇 |
1976年 | 16篇 |
1973年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
Wojciech Szychta M.D. Ph.D. Gheorghe Cerin M.D. Ph.D. F.E.S.C. Bogdan Adrian Popa M.D. Armienti Felice M.D. Guido Lanzillo M.D. Ph.D. Marco Diena M.D. Grzegorz Opolski M.D. Ph.D. F.E.S.C. 《Echocardiography (Mount Kisco, N.Y.)》2015,32(6):1040-1043
Sinus venosus atrial septal defect (SV‐ASD) usually coexists with partial anomalous pulmonary vein connection (PAPVC). It is a difficult diagnosis in transthoracic echocardiography (TTE) due to eccentric position of defects. We present a rare case of atypical anatomical variation in PAPVC, which was never described before. Two right pulmonary veins drained into superior vena cava, which overrode SV‐ASD and interatrial septum, a third pulmonary vein into the right atrium. Complete diagnosis could not be set after TTE, nor transesophageal echocardiography, whereas angio‐CT was finally conclusive. This diagnostic approach allowed the surgical planning. 相似文献
5.
Improvement in Tricuspid Annular Plane Systolic Excursion with Pulmonary Hypertension Therapy in Pediatric Patients
下载免费PDF全文
![点击此处可从《Echocardiography (Mount Kisco, N.Y.)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
6.
7.
《Neuro-Chirurgie》2022,68(4):414-425
Intraoperative monitoring of cerebral blood flow (CBF) has become an invaluable adjunct to vascular and oncological neurosurgery, reducing the risk of postoperative morbidity and mortality. Several technologies have been developed during the last two decades, including laser-based techniques, videomicroscopy, intraoperative MRI, indocyanine green angiography, and thermography. Although these technologies have been thoroughly studied and clinically applied outside the operative room, current practice lacks an optimal technology that perfectly fits the workflow within the neurosurgical operative room. The different available technologies have specific strengths but suffer several drawbacks, mainly including limited spatial and/or temporal resolution. An optimal CBF monitoring technology should meet particular criteria for intraoperative use: excellent spatial and temporal resolution, integration in the operative workflow, real-time quantitative monitoring, ease of use, and non-contact technique. We here review the main contemporary technologies for intraoperative CBF monitoring and their current and potential future applications in neurosurgery. 相似文献
8.
9.
Hui-Ju Ch’ang 《World journal of hepatology》2015,7(16):2029-2040
The success of sorafenib in prolonging survival of patients with hepatocellular carcinoma (HCC) makes therapeutic inhibition of angiogenesis a component of treatment for HCC. To enhance therapeutic efficacy, overcome drug resistance and reduce toxicity, combination of antiangiogenic agents with chemotherapy, radiotherapy or other targeted agents were evaluated. Nevertheless, the use of antiangiogenic therapy remains suboptimal regarding dosage, schedule and duration of therapy. The issue is further complicated by combination antiangiogenesis to other cytotoxic or biologic agents. There is no way to determine which patients are most likely respond to a given form of antiangiogenic therapy. Activation of alternative pathways associated with disease progression in patients undergoing antiangiogenic therapy has also been recognized. There is increasing importance in identifying, validating and standardizing potential response biomarkers for antiangiogenesis therapy for HCC patients. In this review, biomarkers for antiangiogenesis therapy including systemic, circulating, tissue and imaging ones are summarized. The strength and deficit of circulating and imaging biomarkers were further demonstrated by a series of studies in HCC patients receiving radiotherapy with or without thalidomide. 相似文献
10.